Last reviewed · How we verify

NCT06659237

Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients

Completed Last updated 26 October 2024
What this trial tests

trial testing 16s rRNA or shotgun metagenomics in Microbiome in 121 participants. Completed in 30 May 2024.

Timeline
1 November 2020
Primary endpoint
30 May 2024
30 May 2024

Quick facts

Lead sponsorPeking Union Medical College Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment121
Start date1 November 2020
Primary completion30 May 2024
Estimated completion30 May 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking Union Medical College Hospital

Who can join

18 and older, any sex, with Microbiome or Pancreatic Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Significant gaps exist in understanding the gastrointestinal microbiota in patients with pancreatic cancer (PCA) versus benign or low-grade malignant pancreatic tumors (NPCA). This study aimed to analyze these microbiota characteristics and explore their potential use in distinguishing malignant pancreatic lesions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Difference in fecal and oral microbiota between pancreatic cancer and benign/low-grade malignant tumor patients.
    Li P, Zhang H, Gao X, Chen L, et al · · 2024 · cited 4× · PMID 39695939 · DOI 10.1186/s12866-024-03687-6

Verify or expand the search:

Other recruiting trials for Microbiome

Currently open trials in the same condition.

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06659237.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing